Distinguished in Mycobacterium Avium Complex Infections

Rachel M. Thomson

Aubigny Place, 
South Brisbane, QLD, AU 
Distinguished in Mycobacterium Avium Complex Infections
Aubigny Place, 
South Brisbane, QLD, AU 
OverviewLocationsClinical Research

Overview

Rachel Thomson practices in South Brisbane, Australia. Ms. Thomson is rated as a Distinguished expert by MediFind in the treatment of Mycobacterium Avium Complex Infections. Her top areas of expertise are Mycobacterium Avium Complex Infections, Bronchiectasis, Nontuberculous Mycobacterial Lung Disease, and Cystic Fibrosis.

Her clinical research consists of co-authoring 91 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 13 articles and participated in 1 clinical trial in the study of Mycobacterium Avium Complex Infections.

Gender
Female

Locations

Aubigny Place, South Brisbane, QLD, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety & Tolerability, and PK of INS1007 Administered Once Daily for 24 Weeks in Subjects With Non-CF Bronchiectasis - The Willow Study
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety & Tolerability, and PK of INS1007 Administered Once Daily for 24 Weeks in Subjects With Non-CF Bronchiectasis - The Willow Study
Enrollment Status: Completed
Publish Date: March 27, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Pilot Study to Assess the Effect of Intermittent Inhaled Nitric Oxide on the Treatment of Nontuberculous Mycobacteria (NTM) Lung Infection in Cystic Fibrosis and Non-Cystic Fibrosis Patients
A Pilot Study to Assess the Effect of Intermittent Inhaled Nitric Oxide on the Treatment of Nontuberculous Mycobacteria (NTM) Lung Infection in Cystic Fibrosis and Non-Cystic Fibrosis Patients
Enrollment Status: Completed
Publish Date: December 16, 2022
Intervention Type: Device
Study Drug: Nitric Oxide
Study Phase: Not Applicable
View 1 Less Clinical Trial

91 Total Publications

The microbiome and gut-lung axis in nontuberculous mycobacterial pulmonary disease.
The microbiome and gut-lung axis in nontuberculous mycobacterial pulmonary disease.
Journal: PLoS pathogens
Published: October 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Thomson's expertise for a condition
ConditionClose
    View All 10 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile